The first independent VC fund for oral health.
Revere is the first-ever venture fund with a focus on oral health, bringing the best oral and systemic health start-ups and the brightest founders to market by matching them with exceptional investors and industry experts. Jeremy and David have a combined 30+ years of key operator experience, 30+ portfolio start-ups, $800M+ valuation, 4 exits, and 2 IPOs. With an intimate knowledge of the industry, which sees $180bn of spending on dental care annually, Revere can help foster unrivaled strategic partnerships that will improve care delivery, as well as patients’ and providers’ experiences — thereby maximizing value for investors.
While there are many excellent investment opportunities in the industry, our data and track record highlight the value of focusing on Seed and Series A rounds (roughly a 2:1 allocation). In addition, we have carved our space in our portfolio for small allotments to special opportunities (pre-seed, innovation competitions) and follow-on investments (Series B and beyond). We believe our industry reach and expertise would afford the opportunity to take Board seats at many of our portfolio companies.
Our thesis is three-pronged:
Research and Insights:
Our analytically rigorous research process enables us to deliver unique insights. We compiled data from over 300 transactions, comprising the largest database of its kind, and found that investments in early-stage dental start-ups earn higher returns relative to other investments on both an outright and risk-adjusted basis.
Fund Structure and Terms:
We welcome investors both in and out of the industry to join us in revolutionizing oral care and beyond (and earning strong returns along the way)!